{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260326909115/en/Agilent-Receives-FDA-Approval-for-PD-L1-IHC-22C3-pharmDx-in-Esophageal-or-Gastroesophageal-Junction-GEJ-Carcinoma", "message": "News view counter 625350 successfully enlarged"}